Top compounds associated with response to CTC-260F20.3


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.098 0.008
mRNA linifanib CTRPv2 pan-cancer AAC 0.095 0.01
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.097 0.01
mRNA pluripotin CTRPv2 pan-cancer AAC -0.093 0.01
mRNA CIL70 CTRPv2 pan-cancer AAC 0.13 0.01
mRNA CD-1530 CTRPv2 pan-cancer AAC 0.1 0.01
mRNA quizartinib CTRPv2 pan-cancer AAC 0.097 0.01
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.086 0.01
mRNA BRD-K14844214 CTRPv2 pan-cancer AAC -0.099 0.02
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.088 0.02
Download CSV